Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > I see some people have huge expectations..............
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Comment by Nickyfeeon Feb 01, 2020 5:35pm
101 Views
Post# 30629780

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I see some people have huge expectations..............

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I see some people have huge expectations..............
branching out into Europe where the company expects to receive EU-GMP certification for its Canadian operations in Q2 of 2020 and being shipping product immediately thereafter. This year should be a transformative year for Vivo, with the analyst forecasting 5,475 kg of Canadian market shipments, representing a 90% uptick over 2019, and then shipments of 9,650 kg in 2021. The analyst estimates VIVO will generate fiscal 2020 revenue of $47.2 million and an adjusted EBITDA of $(2.6) million and fiscal 2021 revenue of $94.6 million and adjusted EBITDA of $14.7 million.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities